From: Lysine crotonylation in disease: mechanisms, biological functions and therapeutic targets
Disease category | Diseases | Biological context | Kcr level | Biological impact | References |
---|---|---|---|---|---|
Neurological system disorders | Alzheimer’s disease | U251 cells, brain tissues from Alzheimer’s disease mice | ↑H3K27cr | Inhibit endocytosis | |
 | Hypoxic-ischemic encephalopathy | Cerebral cortex and hippocampus tissues from Neonatal hypoxic–ischemic brain damage rats | ↑Pan-Kcr, ↑H3K9cr | SB ameliorates HIE | |
 | Depression | SH-SY5Y cells, prelimbic cortex tissues from chronic social defeat stress mice | ↓Pan-Kcr | CDYL-mediated histone Kcr aggravated stress-induced depression | [58] |
 | Neuropathic pain | The trigeminal ganglia tissues from Cx3cr1GFP mice and complete freund adjuvant induced inflammatory pain mice | ↑Pan-Kcr | Kcr induces macrophage activation and inflammatory | [59] |
 | Neurodevelopmental diseases | Human neural stem/ progenitor cells and P19 embryonal carcinoma cells | ↓Pan-Kcr, ↑H3K9Cr | Activates bivalent promoters to stimulate gene expression in nspc | |
Dental disorders | Osteogenic differentiation of PDLSCs | Human periodontal ligament stem cells | ↑Pan-Kcr | Treatment with sodium crotonate (NaCr) and silencing ACSS2 affected the activation of the PI3K-AKT signaling pathway | [67] |
 | Oral squamous cell carcinoma | CAL27 cells | ↑HSP90AB1 Kcr | HSP90AB1 Kcr in hypoxic conditions may enhance the glycolysis regulation ability in oral squamous cell carcinoma | [68] |
Respiratory system disorders | Chronic obstructive pulmonary disease | Human lung tissues | ↓PanKcr | Kcr impacts chronic obstructive pulmonary disease | [70] |
 | Non-small cell lung cancer | PEM-resistant non-small cell lung cancer cells and H1299 cells | ↓H3K18cr, ↓BEX2 K59cr | Reduce proliferation of PEMresistant non-small cell lung cancer cells | |
Cardiovascular system disorders | Ischemic heart disease | Vascular smooth muscle cells from mice with cardiac I/R injury, volatile mycocytes from isoprenaline induced neonatal rats | ↑IDH3a K199cr, ↑TPM1 K28/29cr | Preserve myocardial function | |
 | Hypertrophic cardiomyopathy | Cardiomyocytes from Echs1 mutant mice and ECHS1-expressing/siechs1 neonatal rats | ↑H3K18cr, ↑H2BK12cr,↑NAE1 K238cr | Kcr is involved in cardiac hypertrophy | |
 | Cardiac dysfunction and arrhythmia | Cardiomyocytes from SIRT1 cardiac specific knockout mice | ↑SERCA2a K120cr | Kcr induces cardiac dysfunction | [78] |
Digestive system disorders | Liver fibrosis | Liver tissues from CCl4 induced liver fibrosis rats | ↓Pan-Kcr, ↓H2BK12cr, ↓H3K18cr | Improve the hepatic structure and fibrotic progression | [72] |
 | Hepatocellular carcinoma | HepG2 cells, liver tissues from Acox2 knockout mice | ↓Crot Kcr, ↓Scp2 Kcr, ↓Hsd17b4 Kcr | Regulate hepatic metabolic homeostasis | [83] |
 |  | Huh-7 cells, HepG2 cells, liver tissues from female balb/c nude mice | ↑PanKcr, ↑LamininA K265/270cr | Promote liver cancer cell proliferation | [36] |
 |  | HepG2 cells and MHCC97 cells, liver tissues from mice with liver tumor | ↑PanKcr, ↑SEPT2 | Promote cell invasive capability | [84] |
 |  | implantation | K74cr |  |  |
 |  | Human hepatoma-derived cells | ↑PanKcr | Inhibit the movement and proliferation of hepatoma cells | [85] |
 | Colorectal cancer | HCT-116 cells, DLD-1 cells, LoVo cells and SW480 cells | ↓H3K27cr | The level of H3K27cr was reduced during DNA damage in colon cancer | |
 |  | Human colorectal cancer tissues | ↑ENO1 K420cr | ENO1 K420cr promotes growth, migration, and invasion of CRC cells | [90] |
 |  | Human PBMCs | ↑H2BK12cr | H2BK12cr may serve as a biomarker | [92] |
 | Pancreatic cancer | PANC-1 cells | ↓MTHFD1 K354/553cr | MTHFD1 Kcr inhibited the development of pancreatic cancer by increasing resistance to ferroptosis | [18] |
Urogenital system disorders | Acute kidney injury | Proximal tubular cells from folic acid induced mice | ↑PanKcr | Against inflammation and mitochondrial stress | [52] |
 | Renal fibrosis | Human distal tubular cells and tubular epithelial cells | ↓PanKcr, ↑H3K9cr | Alleviate IL-1β-dependent macrophage activation and tubular cell senescence, and delay renal fibrosis | |
 | Autosomal dominant polycystic kidney disease | WT 9–12 cells, kidney tissues from CDYL transgenic mice and Pkd1 knockout mice | ↑Pan-Kcr, ↑H3K18cr | Overexpression of CDYL reduces Kcr and slows cyst growth | |
 | Prostate cancer | Human prostate cancer cell lines ( PC-3 cells, LNCaP cells, and C42B cells), human prostate cancer tissues | ↓H3K18cr | Promote the function of Prostate cancer cells | [101] |
Reproductive system disorders | Polycystic ovary syndrome | Ovarian tissues from mice | ↑LONP1 K390cr | Kcr leads to mitochondrial dysfunction and oxidative stress | [102] |
 | Spermatogenesis disorder | Germ cells from mice | / | Regulate escape gene activation from inactive sex chromosomes in post-meiotic spermatids | [14] |
 |  | Spermatogenic cells from mice | ↑PanKcr | Specifically mark testis specific genes | [9] |
 |  | Round spermatid tissues from CDYL transgenic mice | ↓PanKcr, ↓H2BK12cr | CDYL-regulated histone Kcr regulates spermatogenesis and male fertility | [15] |
 | Cervical cancer | Human cervical cancer cells and the normal cervical epithelial cells | ↑Pan-Kcr | Enhance cell proliferation, invasion, and migration of hela cells | [107] |
Infectious disorders | AIDS | Human HIV latency cells | ↑H3K4cr | Viral reactivation | [110] |
 |  | Human jurkat cells of HIV latency | ↑PanKcr | Viral reactivation | [113] |
 | Bacterial infection | Porcine alveolar macrophages after T. Gondii infection from mice | ↓H2BK12cr | Activation of immune response | |
Metabolic disorders | Type 2 diabetes mellitus | HK-2 cells, kidney tissues from diabetic (db/db) mice | ↑H3K27cr | Glucose uptake | |
 | Obesity | White adipocyte tissues from B3-adrenergic receptor (CL316,243) agonist induced the white fat browning mice | ↑PanKcr | Modulation of white fat browning |